For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

CRISPR knock-out cell line publications

Related

  • Knock-out cell lines
    • Knock-out lysates
      • Knock-out cell line or lysate selection tool
        • KO validation: confirming antibody specificity
          • Webinar: Antibody KO validation
            • Fast-track your research with KO cell lines
              • KO validation: Overcoming the perils of poor antibody specificity
                • Applying CRISPR to the drug discovery pipeline
                  • CRISPR cell engineering to speed drug discovery
                    • 5 factors to watch when generating CRISPR KO cell lines

                      Read CRISPR knock-out cell line publications demonstrating the use of these CRISPR cell lines for a range of targets and applications.

                      CRISPR-Cas9 engineered knockout cell lines are helping scientists across the globe to break new boundaries within life science. From validating biotech targets to accelerating the clinical pipeline, CRISPR knock-out cell lines are providing the analytical power to ask new questions, drive new avenues of proteomic research and provide answers that are driving medicine forward.

                      Browse our KO catalog

                      ​

                      Here we have collated some of the most recent key CRISPR knock-out cell line publications, showing how these CRISPR knock-out cell lines are currently being used to push the bounds of biomedical research.

                      • RIPK2 Stabilizes c-Myc and is an actionable target for inhibiting prostate cancer metastasis

                      Yan Y, Zhou B, Qian C, et al. bioRxiv. (2020) doi: https://doi.org/10.1101/2020.05.14.096867

                      CRISPR knockout HEK293T cells negative for RIPK2, MAP2K7, and PRKDC were used in this study to demonstrate the potential of RIPK2 as an actionable drug target for the personalized treatment of advanced prostate cancer, by preventing the activation of the MKK7/JNK/c-Myc phosphorylation pathway and promoting the degradation of c-Myc.

                      • Fenretinide induces a new form of dynamin-dependent cell death in pediatric sarcoma

                      Brack E, Wachtel M, Wolf A, et al. Cell Death Differ. (2020) 27(8):2500-2516

                      CRISPR knock-out cell lines negative for a large dynamin GTPase helped determine a new form of dynamin-dependent programmed cell death mediated through the production of reactive oxygen species by treatment with fenretinide, the drug used for treating childhood sarcomas.

                      • Loss of Caspase-8 function in combination with SMAC mimetic treatment sensitizes Head and Neck Squamous Carcinoma to radiation through induction of necroptosis

                      Uzunparmak B, Gao M, Lindemann A,  et al. bioRxiv (2020) https://doi.org/10.1101/2020.04.17.039040

                      A CRISPR knock-out murine oral squamous cell carcinoma cell line negative for Caspase-8 was used to promote the understanding of the effects of mutations in this gene in head and neck squamous cell carcinoma (HNSCC). CASP8 is shown to regulate necroptosis in HSNCC with the potential to therapeutically exploit this pathway.

                      • Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1 p62 bodies

                      Haidar M, Asselbergh B, Adriaenssens E, et al. Autophagy. (2019) 15(6):1051-1068

                      Using HSPB1-/- CRISPR knockout HeLa cells this paper indicates that the molecular chaperone HSPB1 serves a regulatory role in autophagy via interaction with the SQSTM1/p62 autophagy receptor and show links with peripheral neuropathy in patient-derived motor neurons.

                      • PGAM5-MAVS interaction regulates TBK1/ IRF3 dependent antiviral responses

                      Yu Y, Zielinska M, Li W, Bernkopf DB, et al. Sci Rep. (2020) 20;10(1):8323

                      PGAM5-/- CRISPR knock-out HeLa cells are used to demonstrate the role of PGAM5 in the regulation of IFNß in response to viral infection, as part of the innate immune system.

                      Browse our KO catalog


                      Get resources and offers direct to your inbox Sign up
                      A-Z by research area
                      • Cancer
                      • Cardiovascular
                      • Cell biology
                      • Developmental biology
                      • Epigenetics & Nuclear signaling
                      • Immunology
                      • Metabolism
                      • Microbiology
                      • Neuroscience
                      • Signal transduction
                      • Stem cells
                      A-Z by product type
                      • Primary antibodies
                      • Secondary antibodies
                      • Biochemicals
                      • Isotype controls
                      • Flow cytometry multi-color selector
                      • Kits
                      • Loading controls
                      • Lysates
                      • Peptides
                      • Proteins
                      • Slides
                      • Tags and cell markers
                      • Tools & Reagents
                      Help & support
                      • Support
                      • Make an Inquiry
                      • Protocols & troubleshooting
                      • Placing an order
                      • RabMAb products
                      • Biochemical product FAQs
                      • Training
                      • Browse by Target
                      Company
                      • Corporate site
                      • Investor relations
                      • Company news
                      • Careers
                      • About us
                      • Blog
                      Events
                      • Tradeshows
                      • Conferences
                      International websites
                      • abcam.cn
                      • abcam.co.jp

                      Join with us

                      • LinkedIn
                      • facebook
                      • Twitter
                      • YouTube
                      • Terms of sale
                      • Website terms of use
                      • Cookie policy
                      • Privacy policy
                      • Legal
                      • Modern slavery statement
                      © 1998-2023 Abcam plc. All rights reserved.